The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells.
Open accessAbstract
When a mouse osteoblastic cell line MC3T3-E1 was cultured in the presence of tumor necrosis factor alpha (TNF alpha), the release of prostaglandin E2 and the cyclooxygenase activity increased in a dose- and time-dependent manner. The increase of the enzyme activity was attributed mostly to the induction of cyclooxygenase-2 rather than cyclooxygenase-1 as judged by the inhibitory effect of NS398, Western blotting, and Northern blotting. In this system we attempted to elucidate the transcriptional regulation of the cyclooxygenase-2 gene. As examined by the luciferase assay, two positive regulatory regions (-186 to -131 and -512 to -385 base pairs) were found in the 5'-flanking promoter region of the mouse cyclooxygenase-2 gene in the TNF alpha-stimulated cells. The former included putative NF-IL6 (C/EBP beta) and AP2 elements, and the latter contained the NF kappa B motif. A DNA probe including the NF-IL6 and AP2 sites gave positive bands upon electrophoretic mobility shift assay using the nuclear extracts of MC3T3-E1 cells. The bands were supershifted by the addition of anti-NF-IL6 antibody but not by anti-AP2 antibody. A probe including the NF kappa B site also gave positive bands, which were supershifted by anti-NF kappa B p50 and p65 antibodies. Furthermore, when the motif of NF-IL6 or NF kappa B or both was subjected to point mutation, the luciferase activity was markedly reduced. These data suggested a potential role of both NF-IL6 and NF kappa B in the induction of cyclooxygenase-2 by TNF alpha.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the conundrums is that IL-6 is remarkably noninflammatory in tissues, and although there are some reports that IL-6 induces PGs in non-CNS cells, this seems to be uncommon and to occur at quite high concentrations (57) despite the presence of a nuclear factor IL-6 site upstream of the COX-2 gene (58).”
From Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice (2003) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,754
Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., & Kasai, S. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.96.1.191 · Cited by 1,673
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,542
A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S. M., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,450
The inducible transcription activator NF-κB: regulation by distinct protein subunits
Baeuerle, P. A. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90007-8 · Cited by 1,025
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 902
Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., & Otomo, S. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90074-4 · Cited by 821
Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling
Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., & Krönke, M. (1994) · Cell · doi:10.1016/0092-8674(94)90275-5 · Cited by 714
Flagged first, then by citations
Research works printed but not linked: 4
- Xie, 1994, Mol. Cell. Biol., 14, 6531
- Kusaka, 1988, Biochim. Biophys. Acta, 972, 339
- Isshiki, 1990, Mol. Cell. Biol., 10, 2757
- Baeuerle, 1991, Biochim. Biophys. Acta, 1072, 63
Cited by
Sorted by citations
Items 301–400 of 645
Carter, B. Z., Mak, P. Y., Wang, X., Tao, W., Ruvolo, V. R., Mak, D. H. F., Mu, H., Burks, J. K., & Andreeff, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0921 · Cited by 64
Yin Yang 1 enhancescyclooxygenase-2gene expression in macrophages
Joo, M., Wright, J. G., Hu, N. N., Sadikot, R. T., Park, G. Y., Blackwell, T. S., & Christman, J. W. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00474.2006 · Cited by 62
“Diverse transcription factor binding motifs including CRE binding protein (CREB), NF- B, and C/EBPare identified in a COX-2 promoter, and these transcription factors are known to be crucial in COX-2 gene expression (7, 10, 19, 22, 36, 52, 55, 56, 58).”
BackgroundRegulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins
Callejas, N. A., Boscá, L., Williams, C. S., DuBois, R. N., & Martín‐Sanz, P. (2000) · Gastroenterology · doi:10.1053/gast.2000.9374 · Cited by 62
Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer
Gallego, G. A., Díaz‐Prado, S., Fonseca, P. J., Campelo, R. G., Espinosa, J., & Aparicio, L. M. A. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0126-0 · Cited by 61
“3) by directly blocking the activity of IκB kinase β [55, 56].”
BackgroundNuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy
Aggarwal, B. B., Sethi, G., Nair, S. A., & Ichikawa, H. (2006) · Current Signal Transduction Therapy · doi:10.2174/157436206775269235 · Cited by 61
“Additionally, in some cells, prostaglandin E2 (PGE2) was shown to induce proliferation of tumor cells, and the synthesis of cyclooxygenase-2, which controls PGE2 production, was also shown to be regulated by NF- B activation [129].”
MiRNA‐26b regulates the expression of cyclooxygenase‐2 in desferrioxamine‐treated CNE cells
Ji, Y., He, Y., Liu, L., & Zhong, X. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.036 · Cited by 60
Fahrig, T., Gerlach, I., & Horváth, E. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008177 · Cited by 59
“…inhibited by compound A is primarily regulated at the level of gene transcription and the respective promoter regions contain functional binding sites for both inducible transcription factors (Yamamoto et al., 1995; Read et al., 1997; MarksKonczalik et al., 1998; Ping et al., 1999; Roebuck, 1999).”
BackgroundUp-regulation of cyclooxygenase-2 by interleukin-1β in colon carcinoma cells
Duque, J., Díaz‐Muñoz, M. D., Fresno, M., & Iñiguez, M. A. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.10.009 · Cited by 60
Role of NF-κB in TNF-α-induced COX-2 Expression in Synovial Fibroblasts from Human TMJ
Ke, J., Long, X., Liu, Y., Zhang, Y. F., Li, J., Fang, W., & Meng, Q. G. (2007) · Journal of Dental Research · doi:10.1177/154405910708600412 · Cited by 58
“The NF- B-5 site has been shown to be involved in TNF-induced COX-2 expression in a murine osteoblast cell line (Yamamoto et al., 1995), while the NF- B-3 site, in concert with the nuclear factor-interleukin-6 (NF-IL6) and cyclic adenosine monophosphate response element (CRE) sites, may play a role…”
BackgroundShi, Q., Vaillancourt, F., Côté, V., Fahmi, H., Lavigne, P., Afif, H., Battista, J. A. D., Fernandes, J., & Benderdour, M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2066 · Cited by 58
Park, J., Chung, T., Jeong, Y., Kwak, C.-H., Ha, S., Kwon, K., Abekura, F., Cho, S.-H., Lee, Y., Ha, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171322 · Cited by 58
Kniss, D. A., Rovin, B. H., Fertel, R. H., & Zimmerman, P. D. (2001) · Placenta · doi:10.1053/plac.2000.0591 · Cited by 57
Gupta, M., & Kaur, G. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8497-7 · Cited by 56
“NFκB transcription factor regulates the expression of COX2 and iNOS as their promoter regions contain 10 bp DNA sites called NFκB binding sites and responsible for production of reactive oxygen and nitrogen species during inflammatory neurodegeneration (Lowenstein et al. 1993; Yamamoto et al. 1995; Aid et al. 2008).”
BackgroundElburki, M. S., Rossa, C., Guimarães, M. R., Lee, H., Curylofo‐Zotti, F. A., Johnson, F., & Golub, L. M. (2017) · Inflammation · doi:10.1007/s10753-017-0587-4 · Cited by 58
Anti-inflammatory capabilities of macrolides
Zalewska-Kaszubska, J., & Górska, D. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0884 · Cited by 56
Yeo, S.-J., Gravis, D. P., Yoon, J.-G., & Yi, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302076200 · Cited by 56
Kang, S., Kim, Y. B., Kim, M., Yoon, K., Kim, J., Park, N. H., Song, Y. S., Kang, D., Yoo, K.-Y., Kang, S. B., et al. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.053 · Cited by 56
Oxylipin profiling for clinical research: Current status and future perspectives
Parchem, K., Letsiou, S., Petan, T., Oskolkova, O., Medina, I., Kuda, O., O’Donnell, V. B., Nicolaou, A., Fedorova, M., Bochkov, V., et al. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101276 · Cited by 55
Transcriptional Regulation of the Cyclooxygenase-2 Gene in Macrophages by PU.1
Joo, M., Park, G. Y., Wright, J. G., Blackwell, T. S., Atchison, M. L., & Christman, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306267200 · Cited by 56
Liu, J., Antaya, M., Boerboom, D., Lussier, J. G., Silversides, D. W., & Sirois, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35037 · Cited by 55
Wang, H. Q., Kim, M. P., Tiano, H. F., Langenbach, R. I., & Smart, R. C. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.860 · Cited by 55
Mechanistic Perspectives of Maslinic Acid in Targeting Inflammation
Yap, W. H., & Lim, Y. M. (2015) · Biochemistry Research International · doi:10.1155/2015/279356 · Cited by 54
“In fact, various studies have implicated NF-κB in the transcriptional regulation of COX-2 [57, 58].”
BackgroundFunctional reassessment of P16 variants using a transfection-based assay
Walker, G. J., Gabrielli, B. G., Castellano, M., & Hayward, N. K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990719)82:2 · Cited by 55
Papin, S., Cazeneuve, C., Duquesnoy, P., Jéru, I., Sahali, D., & Amselem, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305166200 · Cited by 54
Kirtikara, K., Raghow, R., Laulederkind, S. J. F., Goorha, S., Kanekura, T., & Ballou, L. R. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007045600664 · Cited by 54
Kundu, J. K., Liu, L., Shin, J.-W., & Surh, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.110 · Cited by 54
Shakibaei, M., Allaway, D., Nebrich, S., & Mobasheri, A. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/509383 · Cited by 53
Wang, D., Chen, Q., Zhang, C., Ren, F., & Li, T. (2012) · European journal of medical research · doi:10.1186/2047-783x-17-12 · Cited by 56
“The nuclear factor responsible for the interleukin-6 expression (NF-IL6) site as one of the critical cites of the COX-2 promoter plays an important role in the regulation of COX-2 expression [16].”
BackgroundClemo, N. K., Collard, T. J., Southern, S. L., Edwards, K. D., Moorghen, M., Packham, G., Hague, A., Paraskeva, C., & Williams, A. C. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn004 · Cited by 53
McCarthy, T. L., Ji, C., Chen, Y., & Kim, K. (2000) · Endocrinology · doi:10.1210/endo.141.1.7237 · Cited by 51
Yoon, D. S., Yoo, J. H., Kim, Y. H., Paik, S., Han, C. D., & Lee, J. W. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0393 · Cited by 52
The Entry and Egress of Monocytes in Atherosclerosis: A Biochemical and Biomechanical Driven Process
Kang, H., Li, X., Xiong, K., Song, Z., Tian, J., Wen, Y., Sun, A., & Deng, X. (2021) · Cardiovascular Therapeutics · doi:10.1155/2021/6642927 · Cited by 57
“In addition, as wementioned before, inflammatory signaling can induce CCL21a production, for example, subcutaneous injection of IL-1b and TNF-α increased the mRNA level of CCL21 in lymphatic endothelial cells [43].”
BackgroundInfluentialCharacterization of Eicosanoids Produced by Adipocyte Lipolysis
Gartung, A., Zhao, J., Chen, S., Mottillo, E. P., VanHecke, G. C., Ahn, Y., Maddipati, K. R., Sorokin, A., Granneman, J. G., & Lee, M.-J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.725937 · Cited by 51
Molecular and cellular mediators of Alzheimer's disease inflammation
Strohmeyer, R., & Rogers, J. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3118 · Cited by 52
Spreading Depression–Induced Gene Expression Is Regulated by Plasma Glucose
Koıstınaho, J., Pasonen, S., Yrjänheikki, J., & Chan, P. H. (1999) · Stroke · doi:10.1161/01.str.30.1.114 · Cited by 51
Jalving, M., Koornstra, J. J., de Jong, S., de Vries, E. G. E., & Kleibeuker, J. H. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02335.x · Cited by 50
CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2
Chen, L., Yibei, Z., Zhang, G., Gao, C., Zhong, W., & Zhang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018994108 · Cited by 51
Flaherty, M. P., Guo, Y., Tiwari, S., Rezazadeh, A., Hunt, G., Sanganalmath, S. K., Tang, X., Bolli, R., & Dawn, B. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.08.014 · Cited by 50
Endothelins Stimulate Expression of Cyclooxygenase 2 in Rat Cultured Astrocytes
Kōyama, Y., Mizobata, T., Yamamoto, N., Hashimoto, H., Matsuda, T., & Baba, A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731004.x · Cited by 50
“…have regulatory sequences by nuclear factor-kB (NF-kB) and cyclic AMP response-element binding protein (CREB) (Kujubu et al., 1991; Appleby et al., 1994), and thus NF-kB and CREB are involved in the transcription of the COX2 gene (Xie et al., 1994; Yamamoto et al., 1995; Gallois et al., 1998).”
BackgroundHarada, S., Tominari, T., Matsumoto, C., Hirata, M., Takita, M., Inada, M., & Miyaura, C. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10193sc · Cited by 49
Hang, C. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1149 · Cited by 49
Cheng, H., & Harris, R. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206040200 · Cited by 49
Kudo, K., Hagiwara, S., Hasegawa, A., Kusaka, J., Koga, H., & Noguchi, T. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.01.007 · Cited by 49
Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth
Achyut, B. R., Angara, K., Jain, M., Borin, T. F., Rashid, M. H., Iskander, A., Ara, R., Kolhe, R. B., Howard, S., Venugopal, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14079-4 · Cited by 48
Transcriptional Regulation of the Human iNOS Gene by IL-1β in Endothelial Cells
Kolyada, A. Y., & Madias, N. E. (2001) · Molecular Medicine · doi:10.1007/bf03402216 · Cited by 48
“Indeed, this is the case for a number of other genes involved in inflammatory and immune responses, including IL-6 (49), IL-8 (50), granulocyte-colony-stimulating factor (51), serum amyloid A protein (52), and cyclooxygenase-2 ( 53 ).”
BackgroundXu, L., Zhang, L., Bertucci, A. M., Pope, R. M., & Datta, S. K. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.08.004 · Cited by 48
Rajakangas, J., Mutanen, M. L., Basu, S., & Salminen, I. (2003) · Journal of Nutrition · doi:10.1093/jn/133.6.1943 · Cited by 48
Han, S., Kım, K., Hahm, E., Lee, S. J., Surh, Y., Park, H. K., Kim, W. S., Jung, C. W., Lee, M. H., Park, K., et al. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20116 · Cited by 47
“Moreover, the COX-2 gene contains many consensus elements for various kinds of transcription factors, including a NF-kB binding site located 223/ 214 bp upstream from the transcription start site [Yamamoto et al., 1995].”
BackgroundTranter, M., Ren, X., Forde, T., Wilhide, M. E., Chen, J., Sartor, M. A., Medvedovic, M., & Jones, W. K. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.07.001 · Cited by 47
Apoptosis and liver diseases: Recent concepts of mechanism and significance1
Ockner, R. K. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02426.x · Cited by 47
POTENTIAL ROLE OF REL/NUCLEAR FACTOR-kappa B IN THE PATHOGENESIS OF INTERSTITIAL CYSTITIS
Abdel‐Mageed, A. B., & Ghoniem, G. M. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62224-9 · Cited by 46
Renal Cyclooxygenase-2 (Cox-2)
Krämer, B. K., Kammerl, M., & Kömhoff, M. (2004) · Kidney & Blood Pressure Research · doi:10.1159/000075811 · Cited by 46
Hernández, M., Fuentes, L., Avilés, F. J. F., Crespo, M. S., & Nieto, M. L. (2002) · Circulation Research · doi:10.1161/hh0102.102978 · Cited by 46
Bonazzi, A., Bolla, M., Buccellati, C., HERNANDEZ, A., Zarini, S., Viganò, T., Fumagalli, F., Viappiani, S., Ravasi, S., Zannini, P., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003127 · Cited by 46
The PPARγ Ligand, 15d-PGJ2, Attenuates the Severity of Cerulein-Induced Acute Pancreatitis
Hashimoto, K., Ethridge, R. T., Saitō, H., Rajaraman, S., & Evers, B. M. (2003) · Pancreas · doi:10.1097/00006676-200307000-00009 · Cited by 45
Crofford, L. J. (2001) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70217-x · Cited by 45
Shen, F., Wang, Y., Lu, Y., Yuan, L., Liu, X., & Guo, S. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.04.040 · Cited by 44
Kaul, R., Verma, S. C., Murakami, M., Lan, K., Choudhuri, T., & Robertson, E. S. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1321-1331.2006 · Cited by 44
“NFB, CRE, and NF-IL-6 have been shown to be important in transcriptional regulation of the COX-2 promoter (24, 25, 86).”
BackgroundNuclear factor‐κB activity is down‐regulated in nasal polyps from aspirin‐sensitive asthmatics
Picado, C., Bioque, G., Roca‐Ferrer, J., Pujols, L., Mullol, J., Benítez, P., & Bulbena, O. (2003) · Allergy · doi:10.1034/j.1398-9995.2003.23792.x · Cited by 44
Gα13 Stimulates Rho-dependent Activation of the Cyclooxygenase-2 Promoter
Slice, L. W., Walsh, J. H., & Rozengurt, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27562 · Cited by 44
Cyclooxygenase-2 Induction in Congestive Heart Failure
Wu, K. K. (1998) · Circulation · doi:10.1161/01.cir.98.2.95 · Cited by 44
Han, E. H., Kim, J. Y., Kim, H.-K., Hwang, Y. P., & Jeong, H. G. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.09.003 · Cited by 43
“To date, NF-κB, AP-1, NF-IL6, CRE and the E-box transcriptional elements have been reported to be involved in COX-2 expression (Yamamoto et al., 1995; Guo et al., 2001; Zhou et al., 2003).”
BackgroundShi, G., Li, D., Fu, J., Sun, Y. P., Li, Y., Qu, R., Jin, X., & Li, D. (2015) · PubMed · Cited by 43
Characterization of human cyclooxygenase 2 gene promoter localization of a TGF-β response element
Yang, X., Hou, F., Taylor, L., & POLGAR, P. R. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(96)00225-4 · Cited by 43
Anand, P., Sung, B., Kunnumakkara, A. B., Rajasekharan, K. N., & Aggarwal, B. B. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.001 · Cited by 42
“NF-κB activation has been shown to regulate the expression of COX-2, cyclin D1, and VEGF [23–25].”
BackgroundRetractedCalpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat
Cuzzocrea, S., McDonald, M. C., Mazzon, E., Mota‐Filipe, H., Centorrino, T., Terranova, M. L., Ciccolo, A., Britti, D., Caputi, A. P., & Thiemermann, C. (2001) · Gut · doi:10.1136/gut.48.4.478 · Cited by 41
Fujimori, K., Fujitani, Y., Kadoyama, K., Kumanogoh, H., Ishikawa, K., & Urade, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208288200 · Cited by 42
Regulation of Cyclo-oxygenase Gene Expression in Rat Smooth Muscle Cells by Catalase
Chen, G., Kamal, M., Hannon, R., & Warner, T. D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00021-5 · Cited by 42
Uchida, T., Honjo, M., Yamagishi, R., & Aihara, M. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22679 · Cited by 41
Stimulus‐specific defect in the phagocytic pathways of annexin 1 null macrophages
Yona, S., Buckingham, J. C., Perretti, M., & Flower, R. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705858 · Cited by 41
“…of annexin 1, lipopolysaccharide activation led to a marked upregulation of COX-2 and iNOS protein expression, and this was associated with a prolonged and more pronounced release of PGE2, this may be due to overactivity at the NFkB promoter, that regulates COX-2 expression (Yamamoto et al., 1995).”
BackgroundKawamura, M., Hatanaka, K., Saito, M., Ogino, M., Ono, T., Ogino, K., Matsuo, S., & Harada, Y. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00377-0 · Cited by 40
Involvement of Rel/NF-κB transcription factors in senescence
Gosselin, K., & Abbadie, C. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.09.007 · Cited by 41
Differential Regulation of COX-2 Transcription by Ras- and Rho-Family of GTPases
Slice, L. W., Bui, L., Mak, C., & Walsh, J. H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3487 · Cited by 41
Godet, I., Oza, H. H., Shi, Y., Joe, N., Weinstein, A. G., Johnson, J., Considine, M., Talluri, S., Zhang, J., Xu, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51995-2 · Cited by 45
Hu, P., Huang, P., & Chen, M. W. (2013) · Cell Biology International · doi:10.1002/cbin.10050 · Cited by 42
“Curcumin negatively regulates LPS-stimulated NF-kB activation NF-kB is a major regulatory component of COX-2 mediated by LPS as COX-2 promoter regions contain NF-kB sites which are necessary for inducing expression of these genes (Yamamoto et al., 1995).”
BackgroundLiu, T., Duo, L., & Duan, P. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/1580427 · Cited by 40
Kosloski, L. M., Ha, D. M., Hutter-Saunders, J. A. L., Stone, D. K., Pichler, M. R., Reynolds, A. D., Gendelman, H. E., & Mosley, R. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06834.x · Cited by 40
“Abbreviations used: a-syn, alpha-synuclein; Ab, beta-amyloid; AD, Alzheimer’s disease; APC, antigen presenting cell; BBB, blood brain barrier; BDNF, brain-derived neurotrophic factor; COX, cyclooxygenase; DTBZ, [11C]-dihydrotetrabenazine; FD, [18F]-fluoroDOPA; Foxp3, forkhead homeobox p3; GA, glatiramer acetate; GDNF,…”
BackgroundInfluentialSung, B., Pandey, M. K., Nakajima, Y., Nishida, H., Konishi, T., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0406 · Cited by 39
Chen, L.-C., Chen, B., Chang, J.-M., & Chang, W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.04.003 · Cited by 40
Sakamoto, A., Yokoyama, Y., UMEMOTO, M., Futagami, M., Sakamoto, T., Bing, X., & Mizunuma, H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602009 · Cited by 39
“Tumour necrosis factor-alpha is a strong inducer of COX-2 expression by stimulating the NFkB system (Yamamoto et al, 1995).”
Backgroundp65 Homodimer activity in distal airway cells determines lung dysfunction in equine heaves
Sandersen, C., Bureau, F., Turlej, R. K., Fiévez, L., Dogné, S., Kirschvink, N. A., & Lekeux, P. M. (2001) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(01)00329-4 · Cited by 39
Ikawa, H., Kameda, H., Kamitani, H., Baek, S. J., Nixon, J. B., Hsi, L. C., & Eling, T. E. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5233 · Cited by 39
Samet, J. M., REED, W., Ghio, A. J., Devlin, R. B., Carter, J. D., Dailey, L. A., Bromberg, P. A., & Madden, M. C. (1996) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(96)80021-4 · Cited by 39
Ruiz‐Ortega, M., Lorenzo, Ó., Rup�rez, M., Esteban, V., Mezzano, S. A., & Egido, J. (2001) · KARGER eBooks · doi:10.1159/000060153 · Cited by 37
Edelblum, K. L., Goettel, J. A., Koyama, T., McElroy, S. J., Yan, F., & Polk, D. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801269200 · Cited by 38
Molecular biology of Barrett's cancer
Atherfold, P. A., & Jankowski, J. A. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.04.003 · Cited by 37
Inflammation in parkinson’s disease
Hald, A., van Beek, J., & Lotharius, J. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_12 · Cited by 37
Garcinone B reduces prostaglandin E2 release and NF-κB-mediated transcription in C6 rat glioma cells
Yamakuni, T., Aoki, K., Nakatani, K., Kondo, N., Oku, H., Ishiguro, K., & Ohizumi, Y. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.023 · Cited by 37
Phospholipase D, tumor promoters, proliferation and prostaglandins
Daniel, L. W., Sciorra, V. A., & Ghosh, S. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00099-2 · Cited by 37
Gunasekaran, S., Venkatachalam, K., & Nalini, N. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3398-5 · Cited by 36
LI, L., Pettit, A. R., Gregory, L. S., & Forwood, M. R. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.005 · Cited by 36
Ebselen abrogates TNFα induced pro‐inflammatory response in glioblastoma
Tewari, R., Sharma, V., Koul, N., Ghosh, A., Joseph, C., Sk, U. H., & Sen, E. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.10.004 · Cited by 38
“Western blot analysis demonstrates expression of pro-inflammatory mediator COX-2 in cells treated with either TNFa or Ebselen or both.”
BackgroundInfluentialShih, K., Kwok, C., & Ho, L.-T. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(20000801)78:2 · Cited by 13
Yue, X., Yang, F., Yang, Y., Mu, Y., Sun, W. Y., Li, W., Xu, D., Wu, J., & Zhu, Y. (2011) · Virology Journal · doi:10.1186/1743-422x-8-118 · Cited by 35
“It has been well established that NF-B, C/EBP, and CREB are the primary transcription factors responsible for the regulation of COX-2 expression [10] [11] [12] [13] .”
BackgroundInfluentialProstaglandin terminal synthases as novel therapeutic targets
Hara, S. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.044 · Cited by 35
Wier, E. M., Neighoff, J., Sun, X., Fu, K., & Wan, F. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.388694 · Cited by 38
Zidan, H. E., Rezk, N. A., Alnemr, A. A. A., & el Ghany, A. M. A. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.06.093 · Cited by 35
“Within the promoter region of the COX-2 gene, the nuclear factor for the interleukin-6 expression site (NF-IL6) is a CpG site that plays a role in the regulation of COX-2 expression (Yamamoto et al., 1995; Murata et al., 2004).”
BackgroundDikopoulos, N., Nussler, A. K., Liptay, S., Bachem, M. G., Reinshagen, M., Stiegler, M., Schmid, R. M., Adler, G., & Weidenbach, H. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00802.x · Cited by 35
Contribution of membrane‐associated prostaglandin E2 synthase to bone resorption
Saegusa, M., Murakami, M., Nakatani, Y., Yamakawa, K., Katagiri, M., Matsuda, K., Nakamura, K., Kudo, I., & Kawaguchi, H. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10356 · Cited by 35
“In osteoblasts, NF-kB, NF-IL6, AP-1, C/EBP-a, -b, CRE and Runx2 are known to be involved in the transcriptional induction of COX-2 (Yamamoto et al., 1995; Harrison et al., 2000; Okada et al., 2000b; Chikazu et al., 2002).”
Background
Metadata
- Authors
- Yamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S.
- Affiliations
- Tokushima University (JP)
- Corresponding author
- Yamamoto, Kei
- Yamamoto, Shozo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-12
- Volume
- 270
- Issue
- 52
- Pages
- 31315-31320
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002708977
- Cited by
- 647
- References
- 38
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 7 · 2023: 2 · 2022: 3 · 2021: 17 · 2020: 8 · 2019: 11 · 2018: 12 · 2017: 8 · 2016: 10 · 2015: 8 · 2014: 10 · 2013: 15 · 2012: 14
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Japan Foundation for Applied Enzymology
- Japan Research Foundation for Clinical Pharmacology
- Kissei
- Ono Pharmaceutical
- Japan Society for the Promotion of Science
- Daiichi Sankyo Company
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- cyclooxygenase-2, NF-κB, NF-IL6, C/EBPβ, TNF-α, transcriptional regulation, prostaglandin E2, MC3T3-E1 cells, osteoblasts, promoter regulation, gene induction
- MeSH terms
- Animals, Base Sequence, DNA-Binding Proteins, Enzyme Induction, Isoenzymes, Molecular Sequence Data, Nuclear Proteins, Oligodeoxyribonucleotides, Promoter Regions, Genetic, Prostaglandin-Endoperoxide Synthases, Regulatory Sequences, Nucleic Acid, Transcription, Genetic, Tumor Necrosis Factor-alpha, NF-kappa B, 3T3 Cells, CCAAT-Enhancer-Binding Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review